Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2. (Q37671961)
Jump to navigation
Jump to search
scientific article published on 10 March 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2. |
scientific article published on 10 March 2014 |
Statements
1 reference
Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2. (English)
1 reference
S Noguchi
M Piccart
G Hortobagyi
A Perez
M Geberth
T Csoszi
E Chouinard
V Srimuninnimit
P Puttawibul
J Eakle
W Feng
H Bauly
M El-Hashimy
T Taran
H A Burris
10 March 2014
1 reference